## **Core Concept**
Betaxolol is a medication used primarily in the treatment of glaucoma and ocular hypertension. It belongs to a class of drugs known as beta blockers, which are commonly used to decrease intraocular pressure. The mechanism involves reducing the production of aqueous humor in the eye.

## **Why the Correct Answer is Right**
Betaxolol is specifically a **selective β1-adrenergic receptor blocker**. This means it primarily blocks β1 receptors, which are predominantly found in the heart but also have some presence in the eye. By selectively blocking these receptors in the eye, betaxolol decreases the production of aqueous humor, thereby lowering intraocular pressure. Its β1 selectivity makes it preferable for patients with certain cardiovascular conditions, as it may have fewer effects on airway resistance and peripheral circulation compared to non-selective beta blockers.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while betaxolol does have some local anesthetic or membrane-stabilizing activity, it is not primarily classified based on this property.
- **Option B:** This option is incorrect because, although beta blockers can have effects that might be considered "anticholinergic" in certain contexts (like reducing aqueous humor production), betaxolol is not classified as an anticholinergic agent.
- **Option C:** This option is incorrect because betaxolol is not primarily a prostaglandin analog; it works through a different mechanism as a beta blocker.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that betaxolol's **selective β1 blockade** makes it a safer choice for patients with asthma or chronic obstructive pulmonary disease (COPD) who require beta-blockade for glaucoma treatment, as it is less likely to induce bronchospasm compared to non-selective beta blockers.

## **Correct Answer:** . Betaxolol.